Reduction in Overall Occurrences of Ischemic Events With Vorapaxar: Results From TRACER [Coronary Heart Disease]

Conclusions
Vorapaxar reduced overall occurrences of ischemic events, but increased bleeding. These exploratory findings broaden our understanding of vorapaxar's potential and expand our understanding of the value of capturing recurrent events.

Clinical Trial Registration
URL: ClinicalTrials.gov. Unique identifier: NCT00527943.

Source: JAHA:Journal of the American Heart Association - July 10, 2014 Category: Cardiology Authors: White, H. D., Huang, Z., Tricoci, P., Van de Werf, F., Wallentin, L., Lokhnygina, Y., Moliterno, D. J., Aylward, P. E., Mahaffey, K. W., Armstrong, P. W. Tags: Coronary Heart Disease Source Type: research